Managing Myotonic Dystrophy Type 1 Complicated by Metabolic Syndrome
Gianluca Pagnoni, Ashraf Nassar, Francesca Grossule, Matteo Paolini, Arianna Maini, Anna Vittoria Mattioli, Giuseppe Boriani, Francesca Coppi · 2024
Read Managing Myotonic Dystrophy Type 1 Complicated by Metabolic Syndrome by Gianluca Pagnoni, Ashraf Nassar, Francesca Grossule, Matteo Paolini, Arianna Maini, Anna Vittoria Mattioli, Giuseppe Boriani, Francesca Coppi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11646923.txt.
Description
Myotonic dystrophy type 1 is the most common form of muscular dystrophy in adults, caused by a repeated stretch of DNA in one gene. Gianluca Pagnoni and co-authors present a case from 2024 in which the disease came paired with metabolic syndrome, the cluster of insulin resistance and blood fat problems. Muscle weakness leads to a sedentary life, which makes that pairing more likely.
The patient could not tolerate the standard statin drugs, so the team turned to a newer mix: PCSK9 inhibitors, ezetimibe, and bempedoic acid. The case shows how that mix can manage blood fats when first-line drugs fail. The authors stress that care for such patients must be tailored, since no set guidance exists for this exact pairing of diseases.
Catalog record
| CREATOR | Gianluca Pagnoni, Ashraf Nassar, Francesca Grossule, Matteo Paolini, Arianna Maini, Anna Vittoria Mattioli, Giuseppe Boriani, Francesca Coppi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |